Table 2.
Multinomial logistic regression to assess the risk of CIN2 progression or persistence using clinical predictors
|
Predictor |
RRR |
95% CI |
p-value |
|
ASCUS |
2.40 |
0.73–7.79 |
0.140 |
|
LSIL |
1.14 |
0.43–2.96 |
0.780 |
|
HSIL |
3.85 |
1.66–8.90 |
0.020 |
|
ASC-H |
1.54 |
1.25–1.89 |
0.030 |
|
HPV16 |
3.77 |
0.78–5.00 |
<0.001 |
|
HPV18 |
4.39 |
1.35–14.33 |
0.014 |
|
Other HR-HPV |
3.62 |
1.55–8.49 |
0.003 |
ASC-H: Atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion (HSIL); ASCUS: Atypical squamous cells of undetermined significance; CI: Confidence interval; CIN2: Cervical intraepithelial neoplasia 2; HPV: Human papillomavirus; HR: High risk; LSIL: Low-grade squamous intraepithelial lesion; RRR: Relative risk ratio